307 related articles for article (PubMed ID: 11533238)
1. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation.
Osborne A; Zhang H; Yang WM; Seto E; Blanck G
Mol Cell Biol; 2001 Oct; 21(19):6495-506. PubMed ID: 11533238
[TBL] [Abstract][Full Text] [Related]
2. Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter.
Osborne AR; Zhang H; Fejer G; Palubin KM; Niesen MI; Blanck G
J Biol Chem; 2004 Jul; 279(28):28911-9. PubMed ID: 15105429
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
Zika E; Greer SF; Zhu XS; Ting JP
Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma protein expression facilitates chromatin remodeling at the HLA-DRA promoter.
Osborne A; Tschickardt M; Blanck G
Nucleic Acids Res; 1997 Dec; 25(24):5095-102. PubMed ID: 9396821
[TBL] [Abstract][Full Text] [Related]
5. Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells.
Wang Y; Curry HM; Zwilling BS; Lafuse WP
J Immunol; 2005 May; 174(9):5687-94. PubMed ID: 15843570
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.
Lu Y; Boss JM; Hu SX; Xu HJ; Blanck G
J Immunol; 1996 Apr; 156(7):2495-502. PubMed ID: 8786310
[TBL] [Abstract][Full Text] [Related]
7. Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line.
Osborne AR; Zhang H; Blanck G
Mol Immunol; 2006 Feb; 43(6):710-6. PubMed ID: 16360016
[TBL] [Abstract][Full Text] [Related]
8. Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A.
Gialitakis M; Kretsovali A; Spilianakis C; Kravariti L; Mages J; Hoffmann R; Hatzopoulos AK; Papamatheakis J
Nucleic Acids Res; 2006; 34(3):765-72. PubMed ID: 16452299
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes.
Lu Y; Tschickardt ME; Schmidt BJ; Blanck G
Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472
[TBL] [Abstract][Full Text] [Related]
10. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression.
Abdulkadir SA; Krishna S; Thanos D; Maniatis T; Strominger JL; Ono SJ
J Exp Med; 1995 Aug; 182(2):487-500. PubMed ID: 7629508
[TBL] [Abstract][Full Text] [Related]
11. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat.
He G; Margolis DM
Mol Cell Biol; 2002 May; 22(9):2965-73. PubMed ID: 11940654
[TBL] [Abstract][Full Text] [Related]
12. Technological advances in the study of HLA-DRA promoter regulation: extending the functions of CIITA, Oct-1, Rb, and RFX.
Niesen MI; Osborne AR; Lagor WR; Zhang H; Kazemfar K; Ness GC; Blanck G
Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):198-205. PubMed ID: 19280058
[TBL] [Abstract][Full Text] [Related]
13. Rescue of major histocompatibility-DR surface expression in retinoblastoma-defective, non-small cell lung carcinoma cells by the MS-275 histone deacetylase inhibitor.
Niesen MI; Blanck G
Biol Pharm Bull; 2009 Mar; 32(3):480-2. PubMed ID: 19252299
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression.
Zhang H; Shepherd AT; Eason DD; Wei S; Diaz JI; Djeu JY; Wu GD; Blanck G
Cell Growth Differ; 1999 Jul; 10(7):457-65. PubMed ID: 10437913
[TBL] [Abstract][Full Text] [Related]
15. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
Wright KL; Ting JP
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase.
Yu J; Angelin-Duclos C; Greenwood J; Liao J; Calame K
Mol Cell Biol; 2000 Apr; 20(7):2592-603. PubMed ID: 10713181
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
[TBL] [Abstract][Full Text] [Related]
19. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
Zhang Y; Dufau ML
J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
[TBL] [Abstract][Full Text] [Related]
20. Association of the mSin3A-histone deacetylase 1/2 corepressor complex with the mouse steroidogenic acute regulatory protein gene.
Clem BF; Clark BJ
Mol Endocrinol; 2006 Jan; 20(1):100-13. PubMed ID: 16109738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
